Leerink Partners Maintains OP Following Diplomat Pharmacy (DPLO) Q1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Diplomat Pharmacy (DPLO) PT Raised to $40 at Credit Suisse
May 12, 2015 8:03 AM EDTCredit Suisse analyst G. Santangelo raised its price target on Outperform-rated Diplomat Pharmacy (NYSE: DPLO) to $40.00 (from $37.00) following Q1 'beat and raise'.
For an analyst ratings summary and ratings history on Diplomat Pharmacy... More
Diplomat Pharmacy (DPLO) Tops Q1 EPS by 1c; Boosts FY15 Outlook
May 11, 2015 4:08 PM EDTDiplomat Pharmacy (NYSE: DPLO) reported Q1 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $625 million versus the consensus estimate of $629.6 million.
Diplomat Pharmacy sees FY2015 EPS of $0.48-$0.51, versus prior guidance of $0.47-$0.50 and the consensus of... More
